Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. WBD
3. NVDA
4. PSKY
5. TSLA
6. AMD
7. USO
8. META
9. AMC
10. NUAI

Go back to Novavax (NVAX) Initiates Phase 2b/3 Hummingbird Trial for COVID-19 Vaccine in Children Aged Six Months Through 11 Years
Novavax, Inc. (NASDAQ: NVAX) Delayed: 10.58 +0.47 (4.65%)
Previous Close $10.11    52 Week High $9.23 
Open $10.38    52 Week Low $1.16 
Day High $10.70    P/E N/A 
Day Low $10.21    EPS $-0.30 
Volume 3,748,167